Month: June 2024

VANCOUVER, British Columbia, June 21, 2024 (GLOBE NEWSWIRE) — Westhaven Gold Corp. (TSX-V: WHN) is pleased to announce that it has closed the non-brokered private placement announced on June 11, 2024. Westhaven has issued a total of 6,685,000 common shares that qualify as “flow-through shares” of the Company for the purposes of the Income Tax Act (Canada) (the “FT Common Shares”) at a price of C$0.23 per FT Common Share for aggregate gross proceeds of $1,537,550.    Proceeds from the Offering will be used to incur “Canadian exploration expenses” (within the meaning of the Income Tax Act (Canada)) related to Westhaven’s projects in British Columbia, Canada. The Company will renounce these expenses to the purchasers of the FT Shares with an effective date of no later than December 31, 2024. The private placement remains subject to...

Publicis Conseil named Agency of the Yearat the 71st Cannes Lions Festival June, 21, 2024 – Paris – Publicis Groupe [Euronext Paris FR0000130577, CAC 40] With 2 grand prix and 16 Lions on iconic brands like Renault, Orange, AXA, BNPP, and Darty, Publicis Conseil, founding agency of Publicis Groupe, has been recognized as the Cannes Lions Agency of the Year. Led by Chief Creative Officer Marco Venturelli, and Agathe Bousquet, President of Publicis France, Publicis Conseil is France’s #1 agency. It ranked second globally at last year’s Cannes Lion Festival and built on that momentum over the past 12 months to take the top spot in 2024. Arthur Sadoun, CEO of Publicis Groupe, commented: “Seeing Publicis Conseil, our group’s mother agency, named as Agency of the Year at the Cannes Lions is a very proud moment for me, Maurice Lévy and everyone...

ROUYN-NORANDA, Quebec, June 21, 2024 (GLOBE NEWSWIRE) — GLOBEX MINING ENTERPRISES INC. (GMX – Toronto Stock Exchange, G1MN – Frankfurt, Stuttgart, Berlin, Munich, Tradegate, Lang & Schwarz, LS Exchange, TTMzero, Düsseldorf and Quotrix Düsseldorf Stock Exchanges and GLBXF – OTCQX International in the US) is pleased to provide a brief update as regards Globex’s Normetal/Normetmar (New Metal) royalty property located at the Town of Normetal, Quebec. Starr Peak Mining Ltd. (Starr Peak) have announced that after analysis of soil, geochemical and VTEM data, that they will “complete a 2-week field program prior to executing the drill phase, with the purpose of validating anomalous areas to refine drilling targets”. A total of 12 target areas have been identified “some of which are located along VTEM (versatile time domain electromagnetic)...

MONTREAL, June 21, 2024 (GLOBE NEWSWIRE) — Aya Gold & Silver Inc. (TSX: AYA, OTCQX: AYASF) (“Aya” or the “Corporation”) is pleased to announce that all nominees listed in the management proxy circular were elected as directors of Aya at its annual general meeting of shareholders (“AGM”) held today. A total of 56,932,471 common shares or 48.92% of Aya’s issued and outstanding common shares at the record date were represented in person or by proxy at the AGM. Detailed results are as below:Director Nominee Votes For % of Votes For Votes Against % of Votes AgainstYves Grou 63,197,505 96.78% 2,102,044 3.22%Ghislane Guedira Bennouna 65,277,972 99.97% 21,578 0.03%Dr. Jürgen Hambrecht 63,050,646 96.56% 2,248,903 3.44%Annie Torkia Lagacé 64,998,413 99.54% 301,137 0.46%Benoit La Salle 60,105,559 92.05% 5,193,991 7.95%Eloïse...

ATHENS, Greece, June 21, 2024 (GLOBE NEWSWIRE) — Dynagas LNG Partners LP (NYSE: “DLNG”) (“Dynagas Partners” or the “Partnership”), an owner and operator of LNG carriers, today announced that it will release its financial results for the first quarter ended March 31, 2024 after market closes in New York on Thursday, June 27, 2024. On the next day, Friday, June 28, 2024 at 10:00 a.m. Eastern Time, the Company’s management will host a conference call and webcast to discuss the earnings results. Conference Call details:Participants should dial into the call 10 minutes before the scheduled time using the following numbers: 877-405-1226 (US Dial-In), or +1 201-689-7823 (US International Dial-In). Please quote “Dynagas” to the operator and/or conference ID 13746983. For additional participant International Toll- Free access numbers,...

LEADING EDGE MATERIALS REPORTS QUARTERLY RESULTS TO APRIL 30, 2024 Vancouver, June 21, 2024– Leading Edge Materials Corp. (“Leading Edge Materials” or the “Company”) (TSXV: LEM) (Nasdaq First North: LEMSE) (OTCQB: LEMIF) (FRA: 7FL) second quarter results for the period ending April 30, 2024. All references to dollar amounts in this release are in Canadian dollars. Recent AnnouncementsOn 19 May 2024, the company announced the appointment of Mr. Kurt Budge as Chief Executive Officer.  On 18 June 2024, the company announced that it has identified extensive Zn-Pb-Ag+/-Cu mineralization in galleries G2 and G7 at the Company’s Bihor Sud Project in Romania.Results of Operations Three Months Ended April 30, 2024, Compared to Three Months Ended January 31, 2024 During the three months ended April 30, 2024 (“Q2 2024”) the Company reported a...

ALK (ALKB:DC / OMX: ALK B / AKBLF) today announced that the full-year financial outlook has been upgraded to reflect better than expected sales performance in Q2 and an improved outlook for the remainder of the year.Revenue is now expected to grow by 12-15% in local currencies (prev.: 10-13%). The EBIT margin is now expected to improve to 18-20% (prev.: 17-19%) vs. 14% in 2023.The full-year revenue outlook has been upgraded primarily to reflect a continued strong momentum in tablet sales, improved performance for injection- and drop-based allergy immunotherapy products (SCIT/SLIT-drops) as well as an improved pricing outlook in parts of Europe. The full-year earnings upgrade is driven by the higher sales growth and continued operational leverage. The earnings outlook still includes one-off costs of approximately DKK 60 million related...

ALK (ALKB:DC / OMX: ALK B / AKBLF) today announced that it has decided to withdraw the Biologic License Application (‘BLA’) for its house dust mite (‘HDM’) sublingual allergy immunotherapy tablet in China. ALK will continue to work with the authorities to obtain regulatory approval of the HDM tablet in China, which may involve establishing additional clinical data in Chinese patients.   The delay in the regulatory approval process does not impact ALK’s financial guidance for 2024, or its ability to reach a 25% EBIT-margin in 2025. Moreover, it does not impact ALK’s ability to meet its previously communicated long-term financial growth ambitions. The BLA for the treatment of persistent moderate-to-severe HDM allergic rhinitis in patients aged 12–65 was accepted for review by the Chinese authorities in February 2023. In March 2022, prior...